RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9885057
SERIAL NO

14952217

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOWARD HUGHES MEDICAL INSTITUTE4000 JONES BRIDGE ROAD CHEVY CHASE MD 20815-6789

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Flotte, Terence Holden, US 23 871
Mueller, Christian Worcester, US 165 1577
Zamore, Phillip D Northborough, US 101 5537

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00